Influence of noradrenaline denervation on MPTP-induced deficits in mice

Journal of Neural Transmission

Volumn 113, Issue 9, 2006, Pages 1119-1129

  Archer, T ^a,b   Fredriksson, A ^c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LINNAEUS UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Attenuation; C57 BL6 mice; DA; DSP4; L Dopa; Locomotion; Motor deficits; Movement disorder; MPTP; NA; PD; Rearing; Restoration; Total activity; Vehicle

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; DRUG VEHICLE; LEVODOPA; NEUROTOXIN; NORADRENALIN; SEROTONIN; SODIUM CHLORIDE; ZIMELDINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CHRONOTHERAPY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DENERVATION; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFECT; GROUPS BY AGE; INJECTION; LOCOMOTION; LOCUS CERULEUS; MALE; MOTOR ACTIVITY; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NORADRENERGIC SYSTEM; OBSERVATION; PARAMETERS OF MEASUREMENT AND ANALYSIS; PRIORITY JOURNAL; REARING; TREATMENT DURATION;

ANIMALS; AUDITORY PATHWAYS; BEHAVIOR, ANIMAL; BENZYLAMINES; BRAIN CHEMISTRY; DENERVATION; DOPAMINE AGENTS; HIPPOCAMPUS; LEVODOPA; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; MPTP POISONING; NEOSTRIATUM; NOREPINEPHRINE; PREFRONTAL CORTEX; SUBSTANTIA NIGRA;

EID: 33747880216     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-005-0402-5     Document Type: Article

References (49)

1. N-E Andén M Grabowska 1976 Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain Eur J Pharmacol 39 275 282
2. T Archer 1982 Serotonin and fear retention in the rat J Comp Physiol Psychol 96 491 516
3. T Archer A Fredriksson 2000 Effects of clonidine and adrenoceptor antagonists on motor activity in DSP4-treated mice. I. Dose, time- and parameter-dependency Neurotox Res 1 235 247
4. T Archer A Fredriksson 2001 Effects of α-adrenoceptor agonists in chronic morphine administered DSP4-treated rats: evidence for functional cross-sensitization Neurotox Res 3 411 432
5. T Archer A Fredriksson 2003 An antihypokinesic action of α2-adrenoceptors upon MPTP-induced behaviour deficits in mice J Neural Transm 110 183 200
6. T Archer S-O Ögren G Johansson SB Ross 1982 DSP4-induced two-way active avoidance impairment: involvement of central and not peripheral noradrenaline depletion Psychopharmacology 76 303 309
7. T Archer AK Mohammed SB Ross U Söderberg 1983 T-maze learning, spontaneous activity and food intake recovery following systemic administration of the noradrenaline neurotoxin, DSP4 Pharmacol Biochem Behav 19 121 130
8. T Archer G Jonsson SB Ross 1984 A parametric study of the effects of the noradrenaline neurotoxin DSP4 on avoidance acquisition and noradrenaline neurons in the CNS of the rat Br J Pharmacol 82 249 257
9. T Archer G Jonsson SB Ross 1985 Active and passive avoidance following the administration of systemic DSP4, xylamine, or p-chloroamphetamine Behav Neural Biol 43 238 249
10. T Archer A Fredriksson G Jonsson T Lewander AK Mohammed SB Ross U Soderberg 1986a Central noradrenaline depletion antagonizes aspects of d-amphetamine-induced hyperactivity in the rat Psychopharmacology 88 141 146
11. T Archer G Jonsson BG Minor C Post 1986b Noradrenergic-serotonergic interactions and nociception in the rat Eur J Pharmacol 120 295 307
12. M Berlan O Rascol 1989 Alpha 2-adrenergic sensitivity in Parkinson's disease Clin Neuropharmacol 12 138 144
13. CW Berridge AJ Dunn 1990 DSP-4-induced depletion of brain norepinephrine produces opposite effects on exploratory behaviour 3 and 14 days after treatment Psychopharmacology 100 504 508
14. AC Dolphin P Jenner CD Marsden 1976a The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or α-methyl-p-tyrosine pre-treated mice Pharmacol Biochem Behav 4 661 670
15. AC Dolphin P Jenner CD Marsden 1976b Noradrenaline synthesis from L-DOPA in rodents and its relationship to motor activity Pharmacol Biochem Behav 5 431 439
16. DJ Dooley H Bittiger KL Hauser SL Bischoff PC Waldmeier 1983a Alteration of central alpha 2- and beta-adrenergic receptors in the rat after DSP4, a selective noradrenergic neurotoxin Neuroscience 9 889 898
17. DJ Dooley E Mogilnicka A Delini-Stula F Waechter A Truog J Wood 1983b Functional supersensitivity to adrenergic agonists in the rat after DSP-4, a selective noradrenergic neurotoxin Psychopharmacology 81 1 5
18. F Fornai L Bassi MT Torracca MG Alessandri V Scalori GU Corsini 1996 Region- and neurotransmitter-dependent species and strain differences in DSP4-induced monoamine depletion in rodents Neurodegeneration 5 241 249
19. F Fornai MG Alessandri MT Torracca L Bassi GU Corsini 1997 Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions J Pharmacol Exp Ther 283 100 107
20. A Fredriksson T Archer 1994 MPTP-induced behavioural and biochemical deficits: a parametric analysis J Neural Transm (PD Sect) 7 123 132
21. A Fredriksson T Archer 2000 Effects of clonidine and α-adrenoceptor antagonists on motor activity in DSP4-treated mice. II. Interactions with apomorphine Neurotox Res 1 249 259
22. A Fredriksson T Archer 2003 Effect of postnatal iron administration on MPTP-induced behavioural deficits and neurotoxicity: behavioural enhancement by L-Dopa-MK-801 co-administration Behav Brain Res 139 31 46
23. A Fredriksson T Palomo TN Chase T Archer 1999a Tolerance to a suprathreshold dose of L-Dopa in MPTP mice: effects of glutamate antagonists J Neural Transm 106 283 300
24. A Fredriksson A Plaznik E Sundström G Jonsson T Archer 1990 MPTP-induced hypoactivity in mice: reversal by L-Dopa Pharmacol Toxicol 67 295 301
25. A Fredriksson N Schroder P Eriksson I Izquierdo T Archer 2001 Neonatal iron potentiates adult MPTP-induced neurodegenerative and functional deficits Parkinsonism Rel Disord 7 97 105
26. J Glowinski LL Iversen 1966 Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain J Neurochem 13 655 669
27. M Goldstein J Engel 1983 Therapeutic potentials of centrally acting dopamine and alpha 2-adrenoceptor agonists J Neural Transm 18 [Suppl] 257 263
28. DJ Heal SA Butler MR Prow WR Buckett 1993 Quantification of alpha 2-adrenoceptors in rat brain after short-term DSP-4 lesioning Eur J Pharmacol 249 37 41
29. RE Heikkila B-A Sieber L Manzino PK Sonsalla 1989 Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in the mouse Mol Chem Neuropathol 10 171 183
30. B Henry AR Crossman 1998 Characterisation of enhanced behavioural responses to L-DOPA following repeated administration in the 6-hydroxydopamine model of Parkinson's disease Exp Neurol 151 334 342
31. G Jonsson H Hallman 1982 Response of central monoamine neurons following an early neurotoxic lesion Bibl Anat 23 76 92
32. G Jonsson H Hallman F Ponzio SB Ross 1981 DSP4 (N-(2-chloroethyl)-N- ethyl-2-bromobenzylamine) - a useful denervation tool for central and peripheral noradrenaline neurons Eur J Pharmacol 72 173 188
33. G Jonsson H Hallman E Sundström 1982 Effects of the noradrenaline neurotoxin DSP4 on the postnatal development of central noradrenaline neurons in the rat Neuroscience 7 2895 2907
34. R Kirk 1995 Experimental design: procedures for the behavioural sciences Brooks/Cole Belmont, CA
35. JW Langston 1985 MPTP neurotoxicity: an overview and characterization of phases of toxicity Life Sci 36 201 206
36. AJ Latigan MR Marien FC Colpaert 1992 Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study Life Sci 50 995 999
37. MR Marien M Briley FC Colpaert 1993 Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice Eur J Pharmacol 236 487 489
38. MR Marien FC Colpaert AC Rosenquist 2004 Noradrenergic mechanisms in neurodegenerative diseases: a theory Brain Res Rev 45 38 78
39. K Nishi T Kondo H Narabayashi 1991 Destruction of norepinephrine terminals in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice reduces locomotor activity induced by L-dopa Neurosci Lett 123 244 247
40. T Persson B Waldeck 1970 Further studies on the possible interaction between dopamine and noradrenaline containing neurons in the brain Eur J Pharmacol 11 315 320
41. F Ponzio H Hallman G Jonsson 1981 Noradrenaline and dopamine interaction in rat brain during development Med Biol 59 161 169
42. C Post ML Persson T Archer BG Minor W Danysz E Sundström 1987 Increased antinociception by alpha-adrenoceptor drugs after spinal cord noradrenaline depletion Eur J Pharmacol 137 107 116
43. M Riekkinen K Kejonen 1998 Reduction of noradrenaline impairs attention and dopamine depletion slows response in Parkinson's disease Eur J Neurosci 10 1429 1435
44. SB Ross 1976 Long-term effects of N-2-chloroethyl-N-ethyl-2- bromobenzylamine hydrochloride on noradrenergic neurons in the rat brain and heart Br J Pharmacol 58 521 527
45. SB Ross L Renyi 1976 On the long-lasting inhibitory effect of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4) on the active uptake of noradrenaline J Pharmacol Pharmac 28 458 459
46. Y Shoulson TN Chase 1976 Clonidine and the antiparkinsonian response to L-Dopa or piribedil Neuropharmacology 15 25 27
47. PK Sonsalla RE Heikkila 1986 The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice Eur J Pharmacol 129 339 345
48. E Sundström A Fredriksson T Archer 1990 Chronic neurochemical and behavioural changes in MPTP-lesioned C57 Bl/6 mice: a model for Parkinson's disease Brain Res 528 181 188
49. D Tarsy JD Parkes 1975 Clonidine in Parkinson's disease Arch Neurol 32 134 136